What is Regenxbio's retained earnings?

Regenxbio (RGNX) reported retained earnings of -$1.22B in Q1 2026.

How has Regenxbio's retained earnings changed year-over-year?

Regenxbio's retained earnings decreased by 31.3% year-over-year, from -$926.07M to -$1.22B.

What is the long-term trend for Regenxbio's retained earnings?

Over 5 years (2020 to 2025), Regenxbio's retained earnings has grown at a 31.3% compound annual growth rate (CAGR), from -$289.07M to -$1.13B.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Regenxbio RGNX Retained Earnings

Retained Earnings at other companies

Regeneron PharmaceuticalsREGN

$36.42B+12.5%

Sarepta Therapeutics, Inc.SRPT

-$4.55B+2.4%

BiogenBIIB

$20.87B+7.0%

BioMarin PharmaceuticalsBMRN

$259.73M+2,983%

EyePoint, Inc. EYPT

-$1.19B-29.6%

Ultragenyx PharmaceuticalRARE

-$4.72B-14.8%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's retained earnings?: Regenxbio (RGNX) reported retained earnings of -$1.22B in Q1 2026.
How has Regenxbio's retained earnings changed year-over-year?: Regenxbio's retained earnings decreased by 31.3% year-over-year, from -$926.07M to -$1.22B.
What is the long-term trend for Regenxbio's retained earnings?: Over 5 years (2020 to 2025), Regenxbio's retained earnings has grown at a 31.3% compound annual growth rate (CAGR), from -$289.07M to -$1.13B.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.